This page contains a Flash digital edition of a book.
ADDITIVE MANUFACTURING


the skin bioprinter and printed in layers on the wound area, an institute representative explained.


“Our studies show that the new skin blends in with the


patient’s existing skin and looks similar to the surrounding skin,” Jackson said.


“You can create thin tissues, but if you try to do it too thick, you can’t do it without getting the nutrients in and the waste out,” he said. “Then everything gets a lot more complicated.”


Ibrahim Tarik Ozbolat, who moved from the University of Iowa to Penn State University within the last year, is work- ing on the vascularization hurdle too, in addition to work on tissue models for the pancreas, brain, bone, cartilage, bone and skin together (for craniofacial defects), and brain tumors. He’s said previously that the biggest challenge is making capillaries, whose internal diameter is of hair-like thinness. “We can make capillaries within hydrogel,” Ozbolat said. “The major problem is still making capillaries and integrating


“In the scaffold-free approach, we confi ne the cells and let the cells deposit some proteins. Making capillaries in a scaffold-free approach is a tough problem right now.” In his lab’s work with 3D-printed pancreatic islets—the clusters of up to hundreds of cells in the pancreas that se- crete insulin and other hormones—the islets sprouted capil- laries into the supporting scaffold, Ozbolat explained. “When you put the islets together the capillaries anasto- mose,” or connect, he said.


Cell Development Examined In addition to vascularization, another hurdle to scale is


related to cell development and tissue formation, said Scott Collins, chief technology offi cer of TeVido BioDevices (Austin, TX), a bioprinting company focused on building custom grafts for breast cancer reconstruction. The fi rm’s fi rst project is to improve nipple reconstruction, in part because plastic surgery results on this part of the reconstructed breast tend to fade and fl atten after a couple of years. “Fundamentally, we don’t fully understand how cells work in the 3D space,” Collins said. “The bioprinters are going to help us assess that and understand how cells work together and how we can lead them down the pathway to the tissue we’re trying to form.”


This sample in a petri dish shows a bioprinted scaffold with bone cells growing into it.


them with larger blood vessels. Also, maintaining their shape and structure.”


Ozbolat explained that his team includes two approaches to getting capillaries to grow: with a scaffold and without. “With the scaffold, we seed the cells and the cells grow within the material,” he said, “while the scaffold degrades.


50 AdvancedManufacturing.org | June 2016


Translation a Formidable Obstacle On a more basic, yet global, level, Collins said there’s work yet to be done on developing an un- derstanding between those work- ing from a biological perspective and those who design, engineer and make the bioprinters the researchers are using. “Make sure you understand the capabilities and abilities of the tool you’re using and applying it from a tissue biology perspective,” Collins said.


Conversely, he said, people working on the mechanics of the printer must understand how much it affects and inter- acts with biology. David Wallace, vice president of MicroFab Technolo- gies Inc. (Plano, TX), is one of those “people working on the mechanics of the printer.” His company worked with Wake


Photo courtesy Penn State University


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130